Associate Director of Flow Cytometry
Dr. Menssen has a PhD (Immunology) from Washington University in St. Louis, where he studied the genetics and clonal evolution underlying progression from MDS to secondary AML via next-generation sequencing. He joined Hematologics in 2021 for the opportunity to pursue flow cytometry for research and clinical applications in hematology and became Associate Director in 2023. He was certified in 2024 as a High Complexity Laboratory Director (HCLD) by the American Board of Bioanalysis. His research interests include the relationship between phenotypic and genotypic abnormalities, biomarker discovery, and the application of MRD testing to patient care.
